Current issues in cigarette smoking among persons living with HIV/AIDS: A growing public health problem surrounded by missing information and misconceptions

Journal of AIDS and Clinical Research

Volumn 3, Issue 7, 2012, Pages

  Miguez, Maria Jose ^a  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84879810644     PISSN: None     EISSN: 21556113     Source Type: Journal    
DOI: 10.4172/2155-6113.1000e109     Document Type: Editorial

References (36)

1. http://www. Who.int/tobacco/en
2. Department of Health and Human Services (2010) Ending the Tobacco Epidemic: A Tobacco Control Strategic Action Plan for the U.S. Department of Health and Human Services. Washington, DC: Office of the Assistant Secretary for Health.
3. Míguez-Burbano M, Shor-Posner G, Perez E, Ashkin D, Rodriguez A, et al. (2004) Tobacco use: the epidemic striking HIV-infected subjects. HIV AIDS Rev 3: 26-32.
4. Lifson AR, Lando HA (2012) Smoking and HIV: Prevalence, Health Risks, and Cessation Strategies. Curr HIV/AIDS Rep 9: 223-230.
5. Tesoriero JM, Gieryic SM, Carrascal A, Lavigne HE (2010) Smoking among HIV positive New Yorkers: prevalence, frequency, and opportunities for cessation. AIDS Behav 14: 824-835.
6. Centers for Disease Control and Prevention (2012) HIV Surveillance Report.
7. Moore RD, Chaisson RE (1999) Natural history of HIV infection in the era of combination antiretroviral therapy. AIDS 13: 1933-1942.
8. Crum-Cianflone NF, Grandits G, Echols S, Ganesan A, Landrum M, et al. (2010) Trends and Causes of Hospitalizations among HIV-infected Persons during the Late HAART Era: What is the Impact of CD4 Counts and HAART Use? J Acquir Immune Defic Syndr 54: 248-257.
9. Furber AS, Maheswaran R, Newell JN, Carroll C (2007) Is smoking tobacco an independent risk factor for HIV infection and progression to AIDS? A systemic review. Sex Transm Infect. 83: 41-46.
10. Marshall MM, McCormack MC, Kirk GD (2009) Effect of Cigarette Smoking on HIV Acquisition, Progression, and Mortality. AIDS Educ Prev 21: 28-39.
11. Paintsil E, Ghebremichael M, Romano S, Andiman WA (2008) Absolute CD4+ T-Lymphocyte Count as a Surrogate Marker of Pediatric Human immunodeficiency virus Disease Progression. Pediatr Infect Dis J 27: 629-635.
12. Francus T, Francus Y, Weksler ME, Becker CG (1987) Effects of tobacco glycoprotein (TGP) on the immune system. III. The effect of aging on the mitogenic response of human peripheral blood lymphocytes to TGP. Cell Immunol 105: 1-8.
13. Feldman JG, Minkoff H, Schneider MF, Gange SJ, Cohen M, et al. (2006) Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the Women's Interagency HIV Study. Am J Public Health 96: 1060-1065.
14. Kuller LH (2008) Elevated levels of IL-6 and D-dimer are associated with increased risk of death in patients with HIV. PLos Medicine 5: e203.
15. SMART Study Group, El-Sadr WM, Grund B, Neuhaus J, Babiker A, et al. (2008) Risk for Opportunistic Disease and Death after Reinitiating Continuous Antiretroviral Therapy in patients with HIV previously receiving episodic therapy: a randomized trial. Ann Intern Med 149: 289-299.
16. Levin J (2009) HIV & HAART Interruption Increase Inflammation and Disease. 16th CROI Conference on Retroviruses and Opportunistic Infections Montreal, Canada.
17. Amirayan-Chevillard N, Tissot-Dupont H, Capo C, Brunet C, Dignat-George F, et al. (2000) Impact of highly active anti-retroviral therapy (HAART) on cytokine production and monocyte subsets in HIV-infected patients. Clin Exp Immunol 120: 107-112.
18. Appay V, Sauce D (2008) Immune activation and inflammation in HIV-1 infection: causes and consequences. J Pathol 214: 231-241.
19. Highleyman L (2010) Inflammation, Immune Activation and HIV.
20. Neuhaus J, Jacobs Jr DR, Baker JV, Calmy A, Duprez D, et al. (2010) Markers of inflammation, coagulation, and renal function are ewlevated in adults with HIV-infection. J Infect Dis 201.
21. Shepp D. Chronic Inflammation & Medical Illness in HIV.
22. Míguez-Burbano MJ, Rosenberg R, Malow R, Burbano X, Devieux J, et al. (2010) The effect of mentholated cigarette use on interleukin-6 responses across different HIV positive race/ethnic subgroups. Int J Infereron Cytokine Mediator Res. 2: 157-164.
23. Heaton R (2010) Persistence and progression of HIV-associated neurocognitive impairment (NCI) in the era of combination antiretroviral therapy (CART) and the role of comorbidities: the CHARTER study. Neurology 75: 2087 2.
24. Cohen R (2009) The Changing Face of HIV-Associated Cognitive and Neuropsychiatric Disturbance. Current Clinical Neurology 133: 1-54.
25. Burns DN, Hillman D, Neaton JD, Sherer R, Mitchell T, et al. (1996) Cigarette smoking, bacterial pneumonia, and other clinical outcomes in HIV-1 infection. Terry Beirn Community Programs for Clinical Research on AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 13: 374-383.
26. Wojna V, Robles L, Skolasky RL, Mayo R, Selnes O, et al. (2007) Associations of cigarette smoking with viral immune and cognitive function in human immunodeficiency virus-seropositive women. J Neurovirol 13: 561-568.
27. Miguez-Burbano MJ, Ashkin D, Rodriguez A, Duncan R, Pitchenik A, et al. (2005) Increased risk of Pneumocystis Carinii and community-acquired pneumonia with tobacco use in HIV disease. Int J Infect Dis 9: 208-217.
28. Miguez-Burbano MJ, Shor-Posner G, Hadrigan S (2005) Non-tuberculous mycobacteria in HIV-infected patients: geographic, behavioural, and immunological factors. Lancet 5: 394-395.
29. Miguez-Burbano MJ, Burbano X, Ashkin D, Pitchenik A, Allan R, et al. (2003) Impact of tobacco use on the development of opportunistic respiratory infections in HIV seropositive patients on antiretroviral therapy. Addict Biol 8: 39-43.
30. Gordin FM, Roediger MP, Girard PM, Lundgren JD, Miro JM, et al. (2008) Pneumonia in HIV-infected persons: increased risk with cigarette smoking and treatment interruption. Am J Respir Crit Care Med 178: 630-636.
31. Rahmanian S, Wewers ME, Koletar S, Reynolds N, Ferketich A, et al. (2011) Cigarette Smoking in the HIV-Infected Population. Proc Am Thorac Soc 8: 313-319.
32. Clifford GM, Lise M, Franceschi S, Egger M, Bouchardy C, et al. (2012) Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection. Br J Cancer 106: 447-452.
33. Míguez-Burbano MJ, Wyatt C, Lewis JE, Rodríguez A, Duncan R (2010) Ignoring the Obvious Missing Piece of Chronic kidney Disease in HIV: Cigarette Smoking. J Assoc Nurses AIDS Care 21: 16-24.
34. DAD Study Group, Friis-Møller N, Reiss P, Sabin CA, Weber R, et al. (2007) Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med 356: 1723-1735.
35. Mendiondo MS, Alexander LA, Crawford T (2010) Health profile differences for menthol and non-menthol smokers: findings from the National Health Interview Survey. Addiction 105: 124-140.
36. http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/TobaccoProductsScientificAdvisoryCommittee/UCM244977.pdf